Work

G6PD-deficiency is associated with improved survival in patients with AML treated with venetoclax and azacitidine

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-6993

Authors: Shira Buchrits, Alon Rozental, Ofer Algor, Shirly Partouche, Galit Granot, Pia Raanani, Ofir Wolach

Institution: Rabin Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417004765

Cites:

Cited by:

Related to: